Strand Life Sciences Pvt

For close to two decades, Strand Life Sciences has been at the forefront of developing robust and sophisticated bioinformatics solutions based on our proprietary platforms fuelling life science research. Software solutions from Strand includes analysis platforms for microarrays, mass spectrometry, next-generation sequencing, high-throughput microscopy, and digital PCR. Our applications cover genomics, transcriptomics, epigenomics to systems biology. Our bioinformatics products are cited in over 25,000 publications. In India, Strand is a leading clinical diagnostics and genomic profiling company with one of the most comprehensive menus of standard-of-care tests in the country covering a vast range of specialties, including oncology, genetics, fertility, women's health, infectious diseases and general wellness. We work with physicians and hospitals to enable faster clinical decision support for accurate clinical and molecular diagnosis, prognosis and therapy recommendations. Strand also offers research and development services to pharmaceutical and biotechnology companies worldwide in the areas of clinical trial management, and biomarker discovery and validation. Strand is a CAP (College of American Pathologists) and NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratory.